MADRIGAL PHARMACEUTICALS, INC. Debt Instrument, Face Amount
MADRIGAL PHARMACEUTICALS, INC. (MDGL) had Debt Instrument, Face Amount of $115.00 million as of 2023-09-30, per its 10-Q filed 2023-11-06.
Discontinued › Notes › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2023-11-06
- 2023-09-30: Debt Instrument, Face Amount $115.00M.
- 2023-06-30: Debt Instrument, Face Amount $100.00M.
- 2023-03-31: Debt Instrument, Face Amount $85.00M.
- 2022-12-31: Debt Instrument, Face Amount $50.00M.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2023-09-30 | $115.00M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $100.00M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $85.00M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $50.00M 10-K/A · filed 2023-03-03 |
| 2022-09-30 | $50.00M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $50.00M 10-Q · filed 2022-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |